Jane Street
OTLK icon

Jane Street’s Outlook Therapeutics OTLK Stock Holding History

Jane Street’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$277K Buy
174,300
+151,200
+655% +$93.8K ﹤0.01% 9397
2026
Q1 		$4.75K Buy
23,100
+5,700
+33% +$2.46K ﹤0.01% 11357
2025
Q4 		$27.5K Buy
17,400
+2,900
+20% +$4.63K ﹤0.01% 10662
2025
Q3 		$15.4K Buy
+14,500
New +$25.1K ﹤0.01% 10558

Other funds holding OTLK

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GWM
Gilpin Wealth Management Denver, Colorado $145M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street's OTLK Position: Q2 2026 in Review

Jane Street opened a new position in Outlook Therapeutics (OTLK) in Q2 2026: 1,425,270 shares worth $2.27M. The stake represents ﹤0.01% of the portfolio and ranks #4948 among its holdings. This is a return to the name: Jane Street previously reported a position in OTLK as recently as Q4 2025.

Jane Street first reported a position in OTLK in Q3 2019 and has held it in 15 quarters since. 69 funds tracked by Wall St. Rank hold OTLK as of Q2 2026.

  • Jane Street held 1,425,270 shares of Outlook Therapeutics worth $2.27M as of Q2 2026.
  • Outlook Therapeutics was a new Jane Street position in Q2 2026.
  • Outlook Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #4948 holding.
  • Jane Street first reported a position in Outlook Therapeutics in Q3 2019 and has held it in 15 quarters since.
  • 69 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.